Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Viramune ER vs IR in Healthy Males
NCT02192463Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2006
- Primary completion
- Aug 2006
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of nevirapine in human immunodeficiency virus infection (HIV) (12 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-Time Curve from 0 to Infinity at 144 hours, Maximum Measured Concentration at 144 hours and 1 more. Started Apr 2006; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02192463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02192463.